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Abstract Although respiratory syncytial virus (RSV) is responsible for more human deaths each
year than influenza, its pathogenic mechanisms are poorly understood. Here high-resolution
quantitative imaging, bioenergetics measurements and mitochondrial membrane potential- and
redox-sensitive dyes are used to define RSV’s impact on host mitochondria for the first time,
delineating RSV-induced microtubule/dynein-dependent mitochondrial perinuclear clustering, and
translocation towards the microtubule-organizing centre. These changes are concomitant with
impaired mitochondrial respiration, loss of mitochondrial membrane potential and increased
production of mitochondrial reactive oxygen species (ROS). Strikingly, agents that target
microtubule integrity the dynein motor protein, or inhibit mitochondrial ROS production strongly
suppresses RSV virus production, including in a mouse model with concomitantly reduced virus-
induced lung inflammation. The results establish RSV’s unique ability to co-opt host cell
mitochondria to facilitate viral infection, revealing the RSV-mitochondrial interface for the first time
as a viable target for therapeutic intervention.
DOI: https://doi.org/10.7554/eLife.42448.001
Introduction
Respiratory syncytial virus (RSV), an enveloped RNA virus of the Pneumoviridae family, is a leading
cause of serious lower respiratory tract illness in infants and a potent respiratory pathogen in elderly
and immunosuppressed adults (Nair et al., 2010; Hall et al., 2009), leading to more deaths each
year worldwide than influenza. Despite this, there are no effective anti-RSV therapeutics generally
available, with palivizumab (Synagis) and ribavirin the only approved agents as a prophylactic and
therapeutic, respectively, for high-risk patients (Hurwitz, 2011; Hebert and Guglielmo, 1990;
Resch, 2017). Like all pneumoviruses, RSV replicates in the cytoplasm (Collins et al., 2013), but spe-
cific interaction with host cell organelles, and the mitochondria in particular, has remained largely
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unexplored. Unbiased discovery studies capitalising on quantitative proteomic protocols to identify
changes in protein levels upon RSV infection have revealed a significant impact on the abundance of
a number of nuclear-encoded mitochondrial proteins (Munday et al., 2015; van Diepen et al.,
2010; Kipper et al., 2015), including respiratory complex I proteins, outer mitochondrial membrane
complex subunits, voltage-dependent anion channel protein, and the prohibitin subunits that play
essential roles in the regulation of mitochondrial dynamics, morphology and biogenesis
(Kipper et al., 2015). The implication is that RSV may have the capacity to impact host cell mito-
chondrial activities, and in keeping with this, we recently were able to document changes in mito-
chondrial morphology during RSV infection (Hu et al., 2017).
Mitochondria are integral to ATP production and reactive oxygen species (ROS) metabolism in
eukaryotic cells. Oxidative phosphorylation driven by ATP synthase/complex V and the electron
transport chain (complexes I-IV) is responsible for up to 90% of cellular ATP production (Schertl and
Braun, 2014; Letts et al., 2016). The electron transport chain carries out a series of redox reactions,
which are tightly coupled to the generation of mitochondrial membrane potential (Dym) through
proton translocation across the inner mitochondrial membrane to drive ATP synthesis (Schertl and
Braun, 2014; Letts et al., 2016). ROS arising from incomplete electron transfer across complexes I
and III are generally cleared by intracellular antioxidant enzymes under normal conditions
(Schertl and Braun, 2014; Letts et al., 2016), but oxidative stress can occur when ROS production
exceeds antioxidant capacity (Lin and Beal, 2006; Schieber and Chandel, 2014). Changes in cyto-
skeletal organization and/or motor activities can impact mitochondrial distribution and function
because mitochondria are trafficked intracellularly through the action of molecular motors operating
on microtubules and actin filaments (Welte, 2004; Hancock, 2014).
Here the RSV-host interface at the level of mitochondrial organization and function is interrogated
in detail for the first time. A unique combination of redox/membrane potential-sensitive/ratiometric
dyes, direct bioenergetics analyses, and high-resolution quantitative imaging/flow cytometric analy-
sis is used to demonstrate that RSV drives a staged redistribution of mitochondria in microtubule-
and dynein-dependent fashion, concomitant with compromised mitochondrial respiration in infected
cells. Inhibiting RSV-induced changes in mitochondrial distribution both restores mitochondrial respi-
ration, and can protect against RSV infection. Further, we show that RSV’s effects on the mitochon-
dria result in enhanced mitochondrial ROS production; importantly, blocking mitochondrial ROS with
a specific inhibitor significantly reduces RSV replication and titers, and alleviates RSV-induced inflam-
mation in a mouse model. The results highlight RSV’s ability to co-opt the host cell mitochondria to
enhance mitochondrial ROS to facilitate virus production, and establish it for the first time as a viable
target for future anti-RSV strategies.
Results
RSV infection drives mitochondrial perinuclear clustering and
redistribution of mitochondria towards the microtubule organizing
centre (MTOC)
Building on our preliminary observations of altered mitochondrial morphology in RSV-infected cells
(Hu et al., 2017), we first performed high resolution Airyscan CLSM imaging of mitochondria in RSV-
infected cells at 8 hr post-infection (p.i.) (Figure 1A). Mock- and RSV-infected cells exhibited frag-
mented, tubular and fibrillar morphologies as revealed by MitoTrackerRed staining (Figure 1A), with
a higher percentage of infected cells showing fragmented morphology, and a lower percentage with
tubular and fibrillar morphologies, compared to uninfected cells (Hu et al., 2013). Quantitative anal-
ysis confirmed the observations, with a significant (p<0.001)>30% increase of cells showing frag-
mented mitochondrial morphology following infection, compared to mock infected cells (Figure 1B).
Clear differences in mitochondrial distribution between mock- and RSV-infected cells were also
evident, whereby perinuclear clusters of mitochondria could be clearly observed in the infected cells
in stark contrast to the even distribution of mitochondria throughout mock-infected cells
(Figure 1A); dynamic perinuclear clustering in the infected but not non-infected cells could be visual-
ised by live cell imaging (compare Figure 1—videos 1 and 2, where mitochondria are imaged using
the CellLight Mitochondria-RFP BacMam 2.0* system). Quantitative analysis to determine the R90%
parameter, the radius of a circle required to enclose 90% of the MitoTrackerRed fluorescence
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Figure 1. RSV infection induces mitochondrial perinuclear clustering early in infection. A549 cells were mock- or RSV-infected (MOI 1) for the times
indicated, followed by staining for mitochondria (MitoTrackerRed), RSV infection (RSV antibody, green) and nuclei (DAPI, blue). (A) Cells were imaged
by Airyscan super-resolution CLSM. Merge panels overlay all three stains; inset (right panels) corresponds to the boxed regions. Scale bar = 5 mm. (B)
Quantification of mitochondrial morphologies following RSV infection. Cells with predominantly fragmented, tubular or fibrillar mitochondrial
morphologies, defined by width/length ratios of 1:1, 1:3 and 1:10 respectively (Hu et al., 2013) were scored by assessing 25–30 cells per condition on
three independent occasions. Data represent the mean ± SEM; ***p<0.001, **p<0.01, *p<0.05 relative to the mock. (C and D) Cells were imaged by
CLSM. (C) Merge panels overlay all three stains. Scale bar = 10 mm. (D) Perinuclear radial distribution of mitochondria (R90%; see Materials and methods)
Figure 1 continued on next page
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relative to the centre of the nucleus (van Bergeijk et al., 2015), confirmed mitochondrial perinuclear
clustering at 8 and 12 h p.i. (Figure 1C). R90% was significantly (p<0.001) reduced (over 30%) at 8 or
12 h p.i. (Figure 1D) compared to mock-infected cells, confirming RSV-induced perinuclear mito-
chondrial clustering early in infection. Intriguingly, asymmetric mitochondrial distribution was
observed at later time points in infection (18 and 24 h p.i.; Figure 2A). By specifically staining for the
microtubule organizing centre (MTOC) using an antibody against the MTOC component g-tubulin
(highlighted by arrows in the merge panels), we could show that the majority of mitochondria are sit-
uated close to the MTOC at 18 or 24 h p.i. (Figure 2A). This asymmetric distribution was confirmed
by our quantitative analysis of the angular distributions of mitochondrial fluorescence (Figure 2B)
towards the axis of the MTOC (red line); quantitation of mitochondrial staining within 45˚ on either
side of the MTOC revealed significantly (p<0.001) increased (40–50%) levels in infected cells at 18
and 24 h p.i. compared to the mock-infected controls (Figure 1C). To confirm that the effects on
host mitochondria are specific, we also tested for changes in the Golgi apparatus by staining using
the CellLight Golgi-GFP *BacMam 2.0* (Figure 1—figure supplement 1). The Golgi cisterna
remained asymmetrically close to the nuclei in mock- and RSV-infected cells (Figure 1—figure sup-
plement 1), in stark contrast to the striking changes in mitochondria at 8 and 24 h p.i. Together,
these findings indicate that RSV infection specifically reorganizes the host cell mitochondria, with
perinuclear clustering followed by MTOC-oriented asymmetry.
To confirm these results to clinically relevant experimental systems, we explored the impact of
RSV on human airway basal cells using an immortalised human airway basal cell line (BCi) derived
from a healthy non-smoker (NS1) capable of multipotent differentiation and responding to extremal
stimuli (Walters et al., 2013). BCi-NS1 cells were infected with RSV for 18 or 36 h p.i. (Figure 1—fig-
ure supplement 2A). In contrast to the even distribution of mitochondria throughout the mock-
infected cells (Figure 1—figure supplement 2A; first two rows), substantial perinuclear mitochon-
drial clustering was observed in RSV-infected cells at 18 and 36 hr (Figure 1—figure supplement
2A; 3rd and 4th rows), completely consistent with our observations in A549 cells (Figure 1). Quantita-
tive analysis of the R90% parameter (Figure 1—figure supplement 2B) confirmed these observations,
whereby R90% was significantly (p<0.01) reduced (over 30%) in RSV-infected cells at 18 or 36 h p.i.,
compared to mock-infected cells. These results were consistent with the idea that RSV induces peri-
nuclear mitochondrial clustering in a clinically relevant model of human infection.
RSV-induced mitochondrial redistribution is microtubule- and dynein-
dependent
Mitochondrial distribution is known to be controlled by cytoskeletal-associated motor proteins
(Boldogh and Pon, 2007). To test whether RSV-induced mitochondrial redistribution requires an
intact cytoskeleton, we treated infected cells with agents that depolymerize/destabilize the actin or
microtubule networks: cytochalasin D (Figure 1—figure supplement 3A) or nocodazole
Figure 1 continued
was calculated from images such as those in C). Results represent the mean ± SEM for n = 3 independent experiments, each of which analysed 25–30
cells per sample; ***p<0.001, **p<0.01. The dashed line represents the average nuclear radius.
DOI: https://doi.org/10.7554/eLife.42448.002
The following video and figure supplements are available for figure 1:
Figure supplement 1. Lack of impact of RSV infection on the Golgi apparatus.
DOI: https://doi.org/10.7554/eLife.42448.003
Figure supplement 2. RSV infection induces mitochondrial perinuclear clustering in immortalised human airway progenitor-like basal cells.
DOI: https://doi.org/10.7554/eLife.42448.004
Figure supplement 3. RSV-induced mitochondrial perinuclear clustering is independent of actin filaments.
DOI: https://doi.org/10.7554/eLife.42448.005
Figure 1—video 1. Mitochondrial dynamics in mock-infected cells.
DOI: https://doi.org/10.7554/eLife.42448.006
Figure 1—video 2. RSV infection induces perinuclear mitochondrial clustering.
DOI: https://doi.org/10.7554/eLife.42448.007
Figure 1—video 3. Nocodazole blocks perinuclear mitochondrial clustering induced by RSV infection.
DOI: https://doi.org/10.7554/eLife.42448.008
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Figure 2. RSV infection induces asymmetric distribution of mitochondria close to the MTOC later in infection. A549 cells were mock- or RSV-infected
(MOI 1) for 8–24 hr, as indicated, and then stained for mitochondria (MitoTrackerRed), RSV infection (RSV antibody, green), MTOC (g-tubulin antibody,
white) and nuclei (DAPI, blue). Cells were imaged by CLSM. (A) Merge panels overlay all four stains; arrows indicate MTOC. In all panels, scale bar = 5
mm. (B and C) Mitochondrial distribution relative to g-tubulin staining was estimated from images such as those in A. (B) Polar kernel density plot
Figure 2 continued on next page
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(Figure 3A), respectively. Significantly, RSV-infected cells continued to show perinuclear clustering
of mitochondria following treatment with cytochalasin D (Figure 1—figure supplement 3B and C)
but not with nocodazole (Figure 3A, Figure 3 - Figure 1—video 3), confirming that RSV-induced
mitochondrial perinuclear clustering is strongly dependent on the integrity of the microtubule net-
work but not the actin cytoskeleton. Quantitative analysis for the R90% parameter reinforced this
observation that RSV-induced mitochondrial redistribution is microtubule-dependent (Figure 3B).
To test the potential role of microtubule motor proteins, we used the agents EHNA (erythro-9-[2-
hydroxy-3-nonyl]adenine) and monastrol that specifically inhibit dynein-dependent (retrograde) and
kinesin-dependent (anterograde) transport along microtubules, respectively. Neither treatment, in
stark contrast to treatment with nocodazole, impacted the filamentous microtubule network, as indi-
cated by a-tubulin staining (Figure 3A; top four rows), as expected. Strikingly, RSV-induced mito-
chondrial perinuclear clustering was completely abolished by treatment with EHNA but not
monastrol. Quantitative analysis for the R90% parameter confirmed this finding (Figure 3B), indicat-
ing that RSV-induced mitochondrial perinuclear clustering relies on dynein-dependent retrograde
transport along intact microtubules.
To further reinforce the contribution of dynein to RSV-induced mitochondrial perinuclear cluster-
ing, we pretreated cells with small interference RNAs (siRNAs) targeting cytoplasmic dynein
(DYNLT1 or DYNC1H1), as well as controls of siRNA targeting kinesin light chain 1 (KLC1)
(Hirokawa et al., 2009) or scrambled siRNA (scr), prior to virus infection. These treatments resulted
in substantial reductions in the cognate target protein levels (Figure 3C), with no impact on the fila-
mentous microtubule network, as expected (see a-tubulin staining in Figure 3D; top four rows).
Consistent with the effects for EHNA above, RSV-induced perinuclear mitochondrial clustering was
suppressed by depletion of either DYNLT1 or DYNC1H1, resulting in an even distribution of reticular
mitochondria (Figure 3D). In contrast, RSV-induced perinuclear mitochondrial clustering was not
affected by depletion of KLC1 (Figure 3D). Quantitative analysis for the R90% parameter supported
these conclusions (Figure 3E), confirming RSV-induced perinuclear redistribution of mitochondria to
be dynein-dependent.
We extended our analysis to the RSV-induced mitochondrial asymmetry that follows mitochon-
drial perinuclear clustering, finding that nocodazole and EHNA treatments prevent the MTOC-ori-
ented mitochondrial asymmetry characteristic of longer (18 hr) RSV infection (Figure 4A).
Quantitative analysis for the angular mitochondrial distribution (Figure 4B–4C) supported this con-
clusion, results overall demonstrating a dynein/microtubule-dependent mechanism underlying RSV-
induced mitochondrial redistribution during the course of infection.
RSV infection inhibits host mitochondrial respiration dependent on
dynein/microtubule integrity
The striking effects of RSV infection on mitochondrial organization prompted us to evaluate the
impact of RSV infection on mitochondrial respiratory function. We used the Seahorse XF96 Extracel-
lular Flux Analyser to measure oxygen consumption rate (OCR) and extracellular acidification rate
(ECAR) of living cells over the time course (6–24 hr) of RSV infection (Figure 5A), as indicators of
mitochondrial respiration and glycolysis, respectively (Wu et al., 2007). OCR progressively
decreased during the RSV infection (Figure 5A, main panel), and was accompanied by increases in
ECAR (Figure 5A, inset) indicating an inhibition of mitochondrial respiration and a parallel increase
in glycolytic metabolism for energy production. These effects paralleled the robustness of infection,
with increasing multiplicity of infection (MOI) resulting in more severe effects (Figure 5—figure sup-
plement 1A).
These observations were extended by performing successive OCR measurements in the presence
of oligomycin (ATP synthase inhibitor), FCCP (proton ionophore), antimycin A (mitochondrial
Figure 2 continued
showing the frequency of angles of mitochondria-stained pixels from the centre of the nucleus, normalised to the position of the MTOC (red line). (C)
Proportion of mitochondrial signal detected within 45˚ either side of the MTOC was quantitated. Results represent the mean ± SEM for n = 3
independent experiments, each of which analysed 25–30 cells per sample; **p<0.01, ***p<0.001.
DOI: https://doi.org/10.7554/eLife.42448.009
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complex III inhibitor) and rotenone (mitochondrial complex I inhibitor) (Figure 5A, Figure 5—figure
supplement 1A); these are all routinely used inhibitors of specific component of the ETC, enabling
the key parameters of mitochondrial metabolic activity (basal, ATP-linked, maximal and non-mito-
chondrial respiration activities) to be determined (Figure 5—figure supplement 1B). Whilst no sig-
nificant changes were observed within 6 h p.i., we observed significant decreases in maximal OCR
(from 8 h p.i.), basal and ATP-linked OCR (from 18 h p.i.); non-mitochondrial OCR was significantly
increased from 8 h p.i. (Figure 5B). These effects again paralleled the robustness of infection, with
increasing multiplicity of infection (MOI) resulting in more severe effects (Figure 5—figure supple-
ment 1C). Thus, the impact of RSV on mitochondrial respiration was to progressively reduce ATP-
linked and maximal respiratory function over the time course of infection.
To assess the extent to which RSV’s impact on mitochondrial respiratory function is linked to RSV-
induced microtubule-dependent mitochondrial redistribution, we treated mock- or RSV-infected cells
with nocodazole or EHNA for 2 hr and then performed Seahorse OCR and ECAR analyses at 18 h
p.i. (Figure 5C). Strikingly, all respiratory activities (basal, ATP-linked, maximal and non-mitochon-
drial) in the RSV-infected cells treated with nocodazole or EHNA remained unchanged (Figure 5C).
Together, these results show that the RSV-induced changes in host cell respiration activities are
dependent on dynein/microtubules.
RSV infection decreases mitochondrial membrane potential (Dcm) but
enhances mitochondrial reactive oxygen species (ROS) generation to
favour virus production
Mitochondrial respiration is required to maintain mitochondrial membrane potential Dym
(Gottlieb et al., 2003; Dey and Moraes, 2000). To assess how RSV impacts Dym, we infected cells
with eGFP-rRSV that has been engineered to express GFP upon host cell infection
(Webster Marketon et al., 2014) to ensure unambiguous identification of RSV-infected cells and
then stained these cells with the Dym-sensitive dye tetramethylrhodamine ethyl ester (TMRE)
(Dejonghe et al., 2016) for live cell imaging over 6–24 h p.i. (Figure 6). The proton ionophore FCCP
was used as a control to give maximal dissipation of the Dym as indicated by the uniform loss of
TMRE fluorescence (Figure 6A, 2nd row of panels). Lower TMRE fluorescence was observed in RSV-
infected cells at 18 and 24 h p.i., an impact strikingly apparent when infected cells were imaged
alongside non-infected cells in the same field (Figure 6A, 5th and 6th rows of panels). Quantification
of the integrated density of TMRE fluorescence confirmed the results, revealing significantly reduced
(p<0.001) Dym at 18 h p.i. (Figure 6B). To monitor these RSV-induced changes in Dym over the
period of 16–18 h p.i. in real time, we used the photobleach-resistant Dym-sensitive dye tetraphenyl-
ethylene-phenyl-indolium salt (TPE-Ph-In) (Zhao et al., 2015), documenting that TPE-Ph-In fluores-
cence was maintained throughout the 2 hr imaging period in mock-infected cells, but showed a
progressive loss of TPE-Ph-In fluorescence at 16 to 18 h p.i. in RSV-infected cells (Figure 6—figure
supplement 1). Thus, by ~18 h p.i., RSV infection induces a loss of host cell mitochondrial membrane
potential, Dym.
In addition to being critical contributors to ATP generation, mitochondria are important sites of
reactive oxygen species production, with modulation of mitochondrial intracellular location recently
gaining interest as a critical mechanism in intracellular redox signalling events (Murphy, 2009; Mur-
phy, 2012). To monitor mitochondrial redox states at different times p.i. directly, we stained cells
with a reversible sensor of mitochondrial ROS, flavin-rhodamine redox sensor 2 (FRR2) (Kaur et al.,
2016) alongside Mitotracker Deep Red to visualise mitochondrial localization. The oxidised form of
Figure 3. RSV-induced mitochondrial perinuclear clustering is microtubule- and dynein-dependent. A549 cells were mock- or RSV-infected (MOI 3) for 8
hr with the indicated agents added in the last 2 hr: (A and B) the microtubule-depolymerizing agent nocodazole (NCZ, 17 mM), the dynein inhibitor
EHNA (200 mM), the kinesin inhibitor monastrol (Mon, 50 mM), or DMSO as a vehicle control. Cells were then stained for mitochondria (MitoTrackerRed),
RSV (RSV antibody, green), a-tubulin (white) and nuclei (DAPI, blue), and cells imaged by CLSM. (A) Merge panels overlay all four stains. (B) The
perinuclear radial distribution of mitochondria (R90%) was calculated as per Figure 1D, ***p<0.001. (C–E) A549 cells were pretreated (48 hr) with siRNA
(50 nM) for dynein light chain Tctex-type 1 (DYNLT1), dynein cytoplasmic 1 heavy chain 1 (DYNC1H1), kinesin light chain 1 (KLC1), or scrambled control
(scr). (C) Immunoblot analysis for DYNLT1, DYNC1H1, KLC1, or the control a-tubulin, as indicated (40 mg cell lysate protein/lane). (D and E) RSV
infection, immunostaining, and R90% analysis were as per (A and B). In all panels, scale bar = 10 mm.
DOI: https://doi.org/10.7554/eLife.42448.010
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Figure 4. RSV-induced asymmetric distribution of mitochondria is microtubule- and dynein-dependent. (A–C) A549 cells were mock- or RSV-infected
(MOI 1) for 18 hr with the indicated treatments over the last 2 hr as per Figure 3AB, followed by staining for mitochondria, RSV, MTOC and nuclei as
per Figure 2A, and imaging by CLSM. (A) Merge panels overlay all four stains; arrows indicate the MTOC. In all panels, scale bar = 10 mm. (B and C)
Polar kernel density of mitochondrial distribution relative to the MTOC analysed as per Figure 2BC. (C) Proportion of mitochondrial signal detected
within 45˚ either side of the MTOC was quantitated. Results represent the mean ± SEM for n = 3 independent experiments, each of which analysed 25–
30 cells per sample. **p<0.01.
DOI: https://doi.org/10.7554/eLife.42448.011
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Figure 5. RSV infection inhibits host mitochondrial respiration in dynein/microtubule-dependent fashion. Cellular bioenergetic analysis was performed
using the Seahorse XF96 Extracellular Flux Analyser. A549 cells were (A and B) mock-infected for 24 hr or RSV-infected (MOI 1) for 6–24 hr or (C) RSV-
infected (MOI 1) for 18 hr with additions of the microtubule-depolymerizing agent nocodazole (NCZ, 17 mM), or the dynein ATPase-inhibitor EHNA (200
mM) over the last 2 hr. (A) An example of a typical oxygen consumption rate (OCR) obtained in these experiments. OCR was measured in real time
upon sequential additions of ATP synthase inhibitor oligomycin (Oligo, 1 mM), proton ionophore FCCP (1 mM), mitochondrial complex III inhibitor
antimycin A (Anti, 1 mM) and mitochondrial complex I inhibitor rotenone (Rot, 1 mM). Inset: Correlation of OCR, a measure of mitochondrial respiration
and extracellular acidification rate (ECAR), an indicator of glycolysis (R2 = 0.9745). (B and C) Mitochondrial respiration function parameters of basal,
ATP-linked, maximal and non-mitochondrial respiration were determined as per Figure 5—figure supplement 1B. Results represent the mean ± SEM
for n = 3 independent experiments, each performed in triplicate. ***p<0.001, **p<0.01, *p<0.05 compared to the mock-infected cells.
DOI: https://doi.org/10.7554/eLife.42448.012
The following figure supplement is available for figure 5:
Figure supplement 1. Correlation of multiplicity of infection (MOI) and effects on host cell mitochondrial respiration.
DOI: https://doi.org/10.7554/eLife.42448.013
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FRR2 emits at 580 nm much more strongly upon excitation at 514 nm than at 488 nm, further
enabling ratiometric live imaging of mitochondrial ROS production in situ (Kaur et al., 2016). We
treated mock-infected cells with rotenone as a positive control, with strong FRR2 emission in regions
colocalizing with Mitotracker Deep Red (Figure 7A, 3rd row of panels), indicative of high levels of
mitochondrial ROS. To confirm the mitochondrial contribution to this staining, we used the mito-
chondrial ROS scavenger mitoquinone mesylate (MitoQ) (Smith and Murphy, 2010;
Maharjan et al., 2014), which strongly suppresses the actions of rotenone (Figure 7A, 4th row of
panels). FRR2 fluorescence increased in RSV-infected cells, but was also reduced by MitoQ
Figure 6. RSV infection disrupts maintenance of mitochondrial membrane potential (Dym). A549 cells were infected without (mock) or with eGFP-rRSV
(MOI 1) for 6–24 hr, as indicated, followed by treatment with DMSO as vehicle or FCCP (5 mM, 10 min). In all cases, the Dym-sensitive dye
tetramethylrhodamine ethyl ester (TMRE, red; 50 nM) was included for the final 15 min. (A) Cells were imaged live by CLSM. Merge panels overlay
TMRE and GFP. Arrows indicate the eGFP-rRSV-infected cells. In all panels, scale bar is 5 mm. (B) Integrated intensity for TMRE fluorescence was
quantified using Fiji software. Results represent the mean ± SEM for n = 3 independent experiments, each of which analysed 15–20 cells per sample
***p<0.001 compared to the mock-infected cells.
DOI: https://doi.org/10.7554/eLife.42448.014
The following figure supplement is available for figure 6:
Figure supplement 1. RSV infection impairs mitochondrial membrane potential (Dym).
DOI: https://doi.org/10.7554/eLife.42448.015
Hu et al. eLife 2019;8:e42448. DOI: https://doi.org/10.7554/eLife.42448 11 of 30
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(Figure 7A; bottom 4 rows of panels). Ratiometric visualization (I(Ex514)/I(Ex488), right column) indi-
cated that the punctate source of ROS causing FRR2 oxidation corresponded to mitochondria
revealed by Mitotracker Deep Red staining (Figure 7A). Quantitative analysis of the ratiometric
images highlighted the extent of ROS production (Figure 7B), with the results indicating that RSV
infection increases mitochondrial ROS generation significantly (p<0.001) by 18 h p.i.
Flow cytometric analysis can exploit the green and red fluorescence emission by the oxidised
form of FRR2 (Kaur et al., 2016). When we analysed cell suspensions from FRR2-stained mock- and
RSV-infected cells, two distinct populations could be discerned: population one showing both higher
red and green emission indicative of FRR2 oxidation through higher mitochondrial ROS generation
and population two with lower emission (Figure 7C). Compared to mock infection, RSV infection at
8 and 18 hr increased population 1 by about 2- and 8-fold, respectively, with these increases
reversed by MitoQ (Figure 7C). Taken together, the results reveal that RSV infection elevates mito-
chondrial ROS generation.
To visualise intracellular ROS production directly in RSV infection, we stained RSV-infected cells at
different times p.i with the intracellular ROS indicator 2’,7’-dichlorodihydrofluorescein diacetate
(DCF) (Al-Mehdi et al., 2012), again alongside Mitotracker Deep Red to enable visualization of mito-
chondrial localization, and also the Hoechst dye to define cell nuclei. We treated mock-infected cells
with rotenone as a positive control, with strong DCF staining in regions colocalized with Mitotracker
Deep Red (Figure 7D, 2nd row) indicating high levels of mitochondrial ROS. Analysis of RSV-infected
cells revealed higher levels of ROS associated with perinuclear mitochondria at 8 h p.i.; this staining
at 12 h p.i. was still perinuclear, but with intense nuclear staining as well as some diffuse cytoplasmic
staining (Figure 7D). To assess the mitochondrial contribution to this ROS staining, we confirmed
the actions of MitoQ to suppress the actions of rotenone (Figure 7D, 3rd row). We then treated
RSV-infected cells with MitoQ 2 hr before imaging and observed a marked reduction in DCF stain-
ing, suggesting that the ROS generated in the absence of MitoQ in infected cells was largely mito-
chondrial (Figure 7D). Strikingly, when we included nocodazole treatment to prevent microtubule-
dependent mitochondrial clustering upon RSV infection, DCF staining remained largely mitochon-
drial and cytoplasmic and was largely excluded from the nucleus (Figure 7D, bottom row). An impli-
cation of these findings is that mitochondrial perinuclear redistribution is a prerequisite for altering
the oxidative status of the host cell nucleus during RSV infection.
To confirm the physiological relevance of the above results with respect to RSV-stimulated mito-
chondrial ROS production in the context of the RSV infectious cycle, MitoQ was tested for its ability
Figure 7. RSV infection enhances mitochondrial reactive oxygen species (ROS) generation, which favours virus production. (A–D) A549 cells were mock-
infected or RSV-infected (MOI 3) for 8, 12 or 18 h p.i., with the the additions as indicated for the final 2 hr prior to staining: the mitochondrial complex I
inhibitor rotenone (Rot, 0.5 mM), the mitochondria-specific ROS scavenger mitoquinone mesylate (MitoQ, 1 mM), NCZ (17 mM) or DMSO as a vehicle; in
the case of dual Rot/MitoQ addition (Rot + MitoQ), Rot was added 4 hr before staining. (A) Cells were stained for Mitotracker Deep Red (white; 100
nM, 15 min) and the mitochondria-specific ROS probe flavin-rhodamine redox sensor 2 (FRR2, red; 2 mM, 15 min prior to imaging). Colocalization for
FRR2 staining at either Ex488 or Ex514 and Mitotracker Deep Red was >85% (Pearson correlation coefficient; Costes et al., 2004) across all samples
(25–30 cells/sample). The ratiometric output images of I(Ex514)/I(Ex488) (far right) were calculated by pixelwise division of FRR2 emission (580 ± 20 nm)
images acquired using excitation at 514 nm (third column) or 488 nm (second column), and are represented in pseudo-colour (intensity colour key
displayed lower right). Live cell imaging was performed by resonant scanning CLSM. Results are typical of 3 independent experiments. In all panels,
scale bar = 10 mm. (B) FRR2 (I(Ex514)/I(Ex488)) was calculated for the mitochondrial regions defined by Mitotracker Deep Red staining in the I(Ex514)/I(Ex488)
images such as those in (A) using a custom CellProfiler pipeline (see Materials and methods). Results represent the mean ± SEM for n = 3 independent
experiments, where each experiment analysed 25–30 cells per sample, ***p<0.001. (C) FACS analysis from single-cell suspensions stained with FRR2.
Green (540/30 nm) and red (585/42 nm) fluorescence was excited at 488 nm. The percentages of cells (50,000/sample) in populations 1 (high red
emission) and 2 (low red emission) determined using FlowJo are indicated. Results were typical of 3 independent experiments. (D) Cells were stained
with Mitotracker Deep Red as for (A), Hoechst nucleic acid dye (blue; 5 mg/ml) and the cellular ROS indicator 2’,7’-dichlorodihydrofluorescein diacetate
(DCF, magenta; 2.5 mM) over the last 5 min before live cell imaging by CLSM. Merge panels overlay all three stains. In all panels, scale bar = 10 mm. (E)
Mock or RSV-infected (MOI 1) A549 cells were treated with MitoQ (1 mM) for the times indicated, followed by cell lysate preparation, with qPCR and
plaque assay performed to determine viral RNA copy number and infectious virus (plaque forming units pfu ml 1) respectively. Results shown represent
the mean ± SEM from three independent experiments assayed in triplicate. ***p<0.001.
DOI: https://doi.org/10.7554/eLife.42448.016
The following figure supplement is available for figure 7:
Figure supplement 1. The mitochondria-targeted antioxidant MitoQ suppresses RSV replication but not virus spread.
DOI: https://doi.org/10.7554/eLife.42448.017
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to inhibit virus production in A549 cells (Figure 7E). Excitingly, addition of MitoQ at 8 or even 18 h
p.i. had a significant (p<0.001) inhibitory effect, reducing viral genome replication by up to 60% and
infectious virus production by up to 3.5 logs measured at 24 h p.i. (Figure 7E). These results confirm
that mitochondrial ROS production contributes essentially to RSV virus production, and that MitoQ,
as a specific inhibitor of mitochondrial ROS, is a potent inhibitor of RSV infection.
To test if mitochondrial ROS generation contributes to the spread of RSV infection through cell
fusion, we tracked syncytia (multinucleated, fused cells) formation in RSV-infected (MOI 0.3) Vero
cells over 24–48 h p.i. in the presence or absence of MitoQ (Figure 7—figure supplement 1A).
MitoQ was found not to alter the density or size of syncytia formed at 48 h p.i. (Figure 7—figure
supplement 1B), suggesting that mitochondrial ROS generation facilitates infectious virus produc-
tion by promoting viral replication rather than enhancing virus spread to neighboring uninfected
cells through cell fusion.
Mitochondrial redistribution is key to RSV-induced mitochondrial ROS
generation.
Previous studies have indicated that microtubule and dynein are necessary for the formation of RSV
infectious virus filaments (Vanover et al., 2017). To confirm the physiological significance of RSV-
induced mitochondrial redistribution, we tested the effect on RSV infectious virus production in
A549 cells of agents inhibiting mitochondrial distribution and/or ROS production. Treatment with
the microtubule/dynein motor targeting agents nocodazole or EHNA significantly (p<0.05) reduced
(up to 2.5 log) infectious virus production (Figure 8—figure supplement 1A), in contrast to the
actin-targeted agent cytochalasin D or the kinesin-inhibitor monastrol that had no significant effect.
Similarly, siRNA-knockdown of proteins of the dynein complex (DYNLT1 or DYNC1H1), but not the
kinesin complex (KLC1), resulted in significant (p<0.001) decreases in infectious virus production (2–
3 logs) compared to the scrambled siRNA control (Figure 8—figure supplement 1B).
None of the treatments above impacting mitochondrial distribution induced by RSV infection,
apart from nocodazole, impact microtubules directly (see Figure 3AD), implying that mitochondrial
redistribution, rather than the microtubule network per se, is key to RSV infection. To examine this
idea further, we performed knockdown experiments for the mRNA-binding protein CLUH (clustered
mitochondria homolog) (Figure 8A), which plays a key role in mitochondrial distribution indepen-
dent of the microtubule network by facilitating translation of nuclear-encoded mitochondrial genes
close to mitochondria (Wakim et al., 2017; Gao et al., 2014). As observed previously
(Wakim et al., 2017; Gao et al., 2014), CLUH-targeting siRNA but not control scrambled siRNA
induced mitochondrial perinuclear clustering in mock infected cells (Figure 8B; first two rows), with
RSV-infection resulting in only a further slight increase in clustering (Figure 8B; 4th row). This was
confirmed by quantitative analysis for the R90% parameter (Figure 8C). Strikingly, the CLUH knock-
down-induced mitochondrial redistribution resulted in elevated mitochondrial ROS production, as
indicated by strong FRR2 emission in regions colocalizing with Mitotracker Deep Red as revealed by
ratiometric live cell imaging in mock-infected cells (Figure 8D; first two rows); RSV infection further
enhanced the effect (Figure 8D; last two rows). Quantitative analysis of the ratiometric images con-
firmed the results, indicating that depletion of CLUH significantly (p<0.01) increased mitochondrial
ROS levels in mock- and RSV-infected cells (Figure 8E).
Finally, the physiological relevance of these results with respect to the RSV infectious cycle could
be confirmed by showing that siRNA-mediated CLUH knockdown resulted in significantly (p<0.01)
increased virus production (Figure 8—figure supplement 1C), The results overall confirm that mito-
chondrial reorganization, rather than the microtubule network per se, is key to RSV infection,
through its link to mitochondrial ROS production.
To confirm that the various drug and siRNA treatments used above limiting RSV infection do not
do so simply by impacting cell viability, we assessed release of the cytosolic enzyme lactate dehydro-
genase (LDH) into the culture medium, indicative of cell death. None of our drug (Figure 8—figure
supplement 2A) or siRNA (Figure 8—figure supplement 2B) treatments significantly increased LDH
release compared to that of controls in either the absence or presence of infection, consistent with
the idea that all of the treatments affecting RSV virus production did so through specific effects on
mitochondrial distribution/mitochondrial ROS production, rather than as a result of toxicity.
Together, the results indicate that mitochondrial ROS generation facilitates RSV infection, with
RSV infection effectively co-opting mitochondria in a microtubule- and dynein-dependent fashion to
Hu et al. eLife 2019;8:e42448. DOI: https://doi.org/10.7554/eLife.42448 14 of 30
Research article Microbiology and Infectious Disease
Figure 8. Knockdown of the clustered mitochondria homolog (CLUH) elicits perinuclear mitochondrial redistribution, elevated mitochondrial ROS
generation, and enhances RSV virus production. (A–E) A549 cells were pretreated (48 hr) with siRNA (50 nM) for clustered mitochondria homolog
(CLUH), or scrambled siRNA control (scr) followed by infection with RSV (MOI 1) for another 24 hr. (A) Immunoblot analysis for CLUH, or the control a-
tubulin, as indicated (40 mg cell lysate protein/lane). (B and C) Immunostaining and R90% analysis were as per (Figure 1C and D). In all panels, scale
Figure 8 continued on next page
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perinuclear/asymmetric mitochondrial distribution that favours reduced mitochondrial respiration
and enhanced mitochondrial ROS production. Blocking RSV induced reorganization of host cell mito-
chondria and increased mitochondrial ROS production thus inhibits RSV infection effectively.
MitoQ protects against RSV infection in primary human bronchial
epithelial cell and mouse models
The results for the A549 human alveolar line indicating that the mitochondrial ROS scavenger MitoQ
can be a potent inhibitor of RSV infection (Figure 7E) were firstly extended by using primary human
bronchial epithelial cells (pBECs) infected with RSV followed by the addition of DMSO (vehicle) or
the mitochondrial ROS scavenger MitoQ for the last 18 hr, prior to assessment of viral replication
and infectious virus production (Figure 8—figure supplement 3). Whereas RSV infection of the vehi-
cle-treated cells resulted in high levels of viral genomes (Figure 8—figure supplement 3A) and
infectious virus titres (Figure 8—figure supplement 3B) at 18 and 36 h p.i., cells treated with MitoQ
showed significantly (p<0.001) reduced numbers of viral genomes (Figure 8—figure supplement
3A;>70%) and infectious virus titres (Figure 8—figure supplement 3B;>4 logs) at both timepoints
p.i. These results were consistent with the idea that elevated mitochondrial ROS is critical for RSV
infection in a clinically relevant human infectious model.
To confirm the contribution of mitochondrial ROS generation to disease in the affected lung in
vivo, we used the established BALB/c mouse model of RSV infection (van Schaik et al., 1998;
Taylor et al., 1984). As previously (van Schaik et al., 1998; Taylor et al., 1984), viral replication
and infectious virus titres peaked at day 5 p.i., declining rapidly at day 7 p.i. (Figure 9AB, black
bars). Mice treated with MitoQ (Figure 9AB, grey bars) showed significantly (p<0.001) reduced (>4
fold) viral replication and infectious virus production compared to the vehicle control for days 4–7
p.i. Importantly, MitoQ treatment resulted in significantly (p<0.001) less dense inflammatory cell infil-
trate (characterised by mononuclear cells and eosinophils) around the bronchial airways
(Figure 9CD) and perivascular regions (Figure 9EF) of the lungs, as revealed by histological section-
ing and objective blind assessment (Ford et al., 2001; Mehra et al., 2012). Consistent with the alle-
viated host response to infection in the case of MitoQ treatment, we observed significantly (p<0.01)
reduced levels of systemic RANTES, a chemokine highly chemoattractant for the inflammatory infil-
trate, upon MitoQ administration throughout (Figure 9G). Taken together, MitoQ treatment sup-
presses RSV infection and decreases virus-induced inflammation in mice, with clear therapeutic
implications.
Discussion
This study shows for the first time that RSV infection co-opts host cell mitochondria to favour infec-
tion; over an 8–24 hr period of infection, RSV progressively impacts the host cell, with mitochondrial
redistribution to a perinuclear location near the MTOC, decreased mitochondrial respiration, a loss
of Dym, and increased mitochondrial ROS generation (Figure 10). These events are dependent on
Figure 8 continued
bar = 10 mm. Results represent the mean ± SEM for n = 3 independent experiments, where each experiment analysed 25–30 cells per sample;
***p<0.001. (D) Cells were stained with Mitotracker Deep Red and the mitochondria-specific ROS probe FRR2 as per Figure 7A. The ratiometric output
images of I(Ex514)/I(Ex488) were calculated as per Figure 7A. (E) FRR2 (I(Ex514)/I(Ex488)) was calculated for the mitochondrial regions defined by Mitotracker
Deep Red staining in the I(Ex514)/I(Ex488) images such as those in D) using a custom CellProfiler pipeline as per Figure 7B. Results represent the
mean ± SEM for n = 3 independent experiments, where each experiment analysed 25–30 cells per sample, ***p<0.001, **p<0.01.
DOI: https://doi.org/10.7554/eLife.42448.018
The following figure supplements are available for figure 8:
Figure supplement 1. Microtubule/dynein-dependent mitochondrial redistribution favours RSV virus production.
DOI: https://doi.org/10.7554/eLife.42448.019
Figure supplement 2. Lack of effect of drug (A) and siRNA (B) treatments used in this study on cell viability.
DOI: https://doi.org/10.7554/eLife.42448.020
Figure supplement 3. Mitochondrial ROS-dependent Effects on RSV Viral replication and infectious virus production in primary human bronchial
epithelial cells (pBECs).
DOI: https://doi.org/10.7554/eLife.42448.021
Hu et al. eLife 2019;8:e42448. DOI: https://doi.org/10.7554/eLife.42448 16 of 30
Research article Microbiology and Infectious Disease
host cell microtubule integrity and dynein, implying that this RSV-induced mitochondrial redistribu-
tion is enacted via a dynein-driven/retrograde-directed mode of transport that is central to the
effects on the host cell; our observations that altering microtubule integrity or dynein activity can
block effects of infection on mitochondrial function as well as RSV infectious virus production reiter-
ate that these events are critical to RSV infection (Figure 10). Interestingly, knockdown of the mito-
chondrial biogenesis factor CLUH appears to be able to further enhance mitochondrial ROS
production in RSV infection (Figure 8) and effect a boost in infectious virus production (Figure 8—
figure supplement 1C), implying that CLUH, in contrast to dynein, functions to limit virus-induced
perinuclear clustering (Figure 10). The most striking observation, however, is that the mitochondrial
ROS scavenger MitoQ can markedly reduce viral replication and infectious virus production
(Figure 7E) as well as restore mitochondrial distribution during infection (Figure 7D), clearly impli-
cating RSV-enhanced mitochondrial ROS production as a key contributor to the infectious process.
Most importantly, blocking mitochondrial ROS generation significantly reduced viral replication/pro-
duction and the extent of lung and systemic inflammation in a mouse model (Figure 9), highlighting
the clinical relevance of our findings.
Oxidative stress is known to play a fundamental role in the pathogenesis of RSV-associated lung
inflammatory disease, correlating strongly with disease severity (Hosakote et al., 2009;
Castro et al., 2006). The mechanism by which elevated ROS contributes to RSV infection may in
part relate to effects at the level of the nucleus, with nuclear ROS (eg. see Figure 7D) impacting
host nuclear gene transcription (Munday et al., 2015; van Diepen et al., 2010; Kipper et al.,
2015). Significantly, progressive increases in lipid peroxidation products in parallel with lowered
reduced glutathione levels in RSV-infected airway epithelial cells indicate the increased oxidative
stress in cells following RSV infection (Hosakote et al., 2009). Antioxidants have been reported to
limit RSV infection in cell culture as well as in mouse models (Hosakote et al., 2009; Castro et al.,
2006; Komaravelli et al., 2015; Zang et al., 2011). This study shows for the first time that treat-
ment with an agent specifically scavenging mitochondrial ROS can limit viremia, significantly reduce
levels of RANTES chemokine and ameliorate lung and systemic inflammation (Figure 9), implying
that modulation of oxidative stress in the context of RSV infection can help diminish lung disease.
This is consistent with the work of Castro et al. (2006), who showed that the antioxidant butylated
hydroxyanisole (BHA) can reduce levels of chemokine (RANTES) and lung inflammation in RSV-
infected mice, as well as the fact that antioxidants have been reported to help alleviate symptoms in
paediatric patients with clinical RSV infection (Dowell et al., 1996; Kawasaki et al., 1999). Thus,
mounting evidence highlights the potential of antioxidants to attenuate symptoms and pathology in
RSV infection.
Importantly, the present study uncovers several novel impacts of RSV infection on host cell mito-
chondria that are relevant to future therapeutic approaches. Specifically, the study shows for the first
time that agents that inhibit microtubule-/dynein-dependent mitochondrial redistribution and/or
reduce mitochondrial ROS limit RSV infection, with MitoQ in particular able to decrease viremia and
airway inflammation in mice. Significantly, MitoQ has been safely delivered in oral form to patients
for up to a year as indicated by two phase II clinical trials (Smith and Murphy, 2010;
Maharjan et al., 2014); clearly, the findings introduce the possibility of using MitoQ or a similar anti-
oxidant as an effective anti-RSV agent. Therapeutic modulation of host cell mitochondrial ROS pro-
duction thus presents itself as an exciting possibility to counteract RSV infection.
Materials and methods
Key resources table
Reagent type
(species) or
resource Designation
Source or
reference Identifiers
Additional
information
Strain
(Respiratory
Syncytial Virus)
RSV A2 strain PMID: 27464690
Continued on next page
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Continued
Reagent type
(species) or
resource Designation
Source or
reference Identifiers
Additional
information
Strain, Strain
background
(Respiratory
Syncytial Virus)
eGFP-rRSV PMID: 24418538 Gift from
Michael N Teng,
University of
South Florida
Mouse strain,
(M. musculus)
BALB/c The Jackson
Laboratory
#: 000651
Genetic reagent
(H. sapiens)
DYNLT1 (siRNA) GE Dharmacon,
SMART pool
#: 6993 Used for
transfection (50 nM)
Genetic reagent
(H. sapiens)
DYNC1H1 (siRNA) GE Dharmacon,
SMART pool
#: 1778 Used for
transfection (50 nM)
Genetic reagent
(H. sapiens)
KLC1 (siRNA) GE Dharmacon,
SMART pool
#: 3831 Used for
transfection (50 nM)
Genetic reagent
(H. sapiens)
CLUH (siRNA) GE Dharmacon,
SMART pool
#: 23277 Used for
transfection (50 nM)
Cell line
(H. sapiens)
A549 ATCC CCL-185 Mycoplasma tested
and/or STR profiled
Cell line
(Chlorocebus sp.)
Vero ATCC CCL-81
Cell line
(H. sapiens)
BCi-NS1 PMID: 24298994 Provided by
Alan Hsu,
Philip M Hansbro,
and Peter AB Wark,
University of
Newcastle
Primary
Cells (H. sapiens)
pBECs PMID: 15781584 Provided by
Alan Hsu,
Philip M Hansbro,
and Peter AB Wark,
University of
Newcastle
Antibody Goat polyclonal
anti-RSV
Abcam Cat. #: ab20745,
RRID:AB_777677
IF (1:400)
Antibody Mouse
monoclonal
anti-g-tubulin
Proteintech Cat. #: 66320–1-Ig IF (1:300)
Antibody Mouse
monoclonal
anti-a-tubulin
Santa Cruz Cat. #: sc-5286,
RRID: AB_628411
IF (1:100), WB
(1:5000)
Antibody Rabbit polyclonal
anti-Goat IgG,
Secondary
Antibody,
Alexa Fluor 488
ThermoFisher
Scientific
Cat. #: 11078
RRID: AB_2534122
IF (1:1000)
Antibody Donkey
polyclonal
anti-Mouse IgG,
Secondary
Antibody, Alexa
Fluor 647
ThermoFisher
Scientific
Cat. #: A-31571,
RRID: AB_162542
IF (1:1000)
Antibody Alexa Fluor
488 phalloidin
ThermoFisher
Scientific
Cat. #: A12379,
RRID: AB_2315147
IF (1:1000)
Antibody Mouse
monoclonal
anti-DYNC1H (C-5)
Santa Cruz Cat. #: sc-514579 WB (1:500)
Continued on next page
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Continued
Reagent type
(species) or
resource Designation
Source or
reference Identifiers
Additional
information
Antibody Mouse
monoclonal
anti-DYNLT1
(H-11)
Santa Cruz Cat. #: sc-365567,
RRID: AB_10841719
WB (1:1000)
Antibody Mouse
monoclonal
anti-KLC1 (L2)
Santa Cruz Cat. #: sc-58776,
RRID: AB_784214
WB (1:1000)
Antibody Rabbit
polyclonal
anti-CLUH
ThermoFisher
Scientific
Cat. #: PA5-71324,
RRID: AB_2690757
WB (1:1000)
Antibody Goat polyclonal
anti-Mouse IgG,
HRP Conjugate
Antibody
Promega Cat. #: W4021,
RRID: AB_430834
WB (1:10,000)
Recombinant
DNA reagent
CellLight Golgi-
GFP *BacMam
2.0*
ThermoFisher
Scientific
Cat. #: C10592
Recombinant
DNA reagent
CellLight Mitochondria-
RFP *BacMam 2.0*
ThermoFisher
Scientific
Cat. #: C10601
Commercial
assay or kit
Mouse RANTES
ELISA Kit
RayBiotech Inc Cat. #: ELM-RANTES
Commercial
assay or kit
LDH Cytotoxicity
Detection Kit
Roche Applied
Science
Cat. #:
11644793001
Commercial
assay or kit
TMRE Dym
Assay Kit
Abcam Cat. #: ab113852 Live-cell IF
(50 nM)
Chemical
compound,
drug
Oligomycin Seahorse XF
Cell Mito Stress
Test Kit
Cat. #: 103015–100 SBA (1 mM)
Chemical
compound,
drug
FCCP Seahorse XF
Cell Mito Stress
Test Kit
Cat. #: 103015–100 SBA (1 mM)
Chemical
compound,
drug
Antimycin A Seahorse XF
Cell Mito Stress
Test Kit
Cat. #: 103015–100 SBA (1 mM)
Chemical
compound,
drug
Rotenone Seahorse XF
Cell Mito Stress
Test Kit
Cat. #: 103015–100 SBA (1 mM)
Chemical
compound,
drug
MitoQ Health
Manufacturing,
New Zealand
Gift from Health
Manufacturing,
New Zealand
PA (0.5 mM),
IF (1 mM)
Chemical
compound,
drug
Nocodazole Sigma Cat. #: M1404 PA and
IF (17 mM)
Chemical
compound,
drug
EHNA Sigma Cat. #: E114 PA and
IF (200 mM)
Chemical
compound,
drug
Monastrol Sigma Cat. #: M8515 PA and
IF (50 mM)
Chemical
compound,
drug
Cytochalasin D Sigma Cat. #: C8273 PA and
IF (2 mM)
Software,
algorithm
Application Suite
Advanced
Fluorescence Lite
Leica RRID:SCR_013673 Version: 2.8.0,
Build: 7266
Continued on next page
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Reagent type
(species) or
resource Designation
Source or
reference Identifiers
Additional
information
Software,
algorithm
ZEN 2 Zeiss RRID:SCR_013672 Blue edition
Software,
algorithm
Fiji Fiji (https://fiji.sc/) RRID:SCR_002285 Version 2.0.0-rc-64,
Build: e0512e3c19
Software,
algorithm
Custom Scripts for
Quantitative
Analysis of
Mitochondrial
Distribution
Programmed
in Python
This paper Quantitative analyses
of mitochondrial
organization
can be
accessed via https://gitlab.
erc.monash.edu.au/mmi/mito
(Schulze, 2018; copy archived at
https://github.com/
elifesciences-publications/mito)
Software,
algorithm
FlowJo Tree Star,
Inc (http://www.
flowjo.com)
RRID:SCR_000410 Version 10.5.3
Software,
algorithm
GraphPad Prism GraphPad
Prism (https://
graphpad.com)
RRID:SCR_015807 Version 6
Software,
algorithm
CellProfiler Broad Institute
Inc (http://
cellprofiler.org/)
RRID:SCR_007358 Version 3.1.8
Other DAPI stain Sigma Cat. #:
10236276001
IF (1:15000)
Other MitoTrackerRed
CMXRos
ThermoFisher
Scientific
Cat. #: M7512 IF (100 nM)
Other Hoechst stain
(33342)
ThermoFisher
Scientific
Cat. #: H3570 Live-cell IF
(1:2000)
Other TPE-Ph-In PMID: 26264419 Gift from
Yuning Hong,
La Trobe University
Live-cell IF
(1:2 mM)
Other DCF ThermoFisher
Scientific
Cat. #: D399 Live-cell IF
(2.5 mM)
Other Mitotracker
Deep Red
ThermoFisher
Scientific
Cat. #: M22426 Live-cell IF
(100 nM)
Other FRR2 PMID:
26865422
Gift from
Jacek L Kolanowski
and Elizabeth J New,
the University of Sydney
Live-cell IF (2 mM)
Other Biomeda
Gel Mount
ProSciTech Cat. #: EMS17985-11
Other DharmaFECT
siRNA transfection
reagent
GE Dharmacon Cat. #: T-2001–04
IF - immunofluorescence, PA- plaque assay, SBA - Seahorse Bioenergetics Analysis, WB - Western blot.
Cell culture, RSV infection and RSV growth
All cells/cell lines were confirmed mycoplasma free by regular testing. They were maintained in a
humidified atmosphere (5% CO2, 37˚C) and passaged (3 day intervals) by dissociation with trypsin-
EDTA (Gibco). A549 cells (human adenocarcinoma alveolar basal epithelial cells) were grown in
Ham’s F-12K (HF-12K) medium containing 2 mM L-glutamine (Gibco), 1.5 gl 1 sodium bicarbonate,
10% heat-inactivated fetal calf serum (FCS; DKSH Australia Pty Ltd) and 100 U ml 1 penicillin and
streptomycin (Gibco). Vero cells (African green monkey kidney epithelial cells) were grown in Dulbec-
co’s modified Eagle’s medium (DMEM, Gibco) containing 2% heat-inactivated FCS. A549 (ATCC:
CCL-185) and Vero (ATCC: CCL-81) lines have been verified by STR profiling.
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Figure 9. The mitochondrial ROS scavenger MitoQ reduces RSV virus production in mice, concomitant with reduced inflammation. BALB/c mice were
intranasally inoculated with 50 ml of 2.5  105 pfu of rRSV or an equivalent volume of diluent at day 0 and given water containing MitoQ (500 mM) or
fresh water ad libitum each day. five mice from each treatment group (total of 20 mice) were euthanased on the days p.i. indicated, and samples
collected for analysis. (A and B) One lung from each animal was put into 1 mL of diluent with steel beads and frozen at  80˚C. Lungs were
subsequently homogenised in a tissue-lyser, debris removed by centrifugation and the supernatant used immediately for (A) virus genome analysis by
qPCR and (B) quantification of infectious virus (plaque forming units or pfu/lung) by plaque assay. (C–F) The other lung was fixed in formalin,
embedded in paraffin, sectioned and stained with haemotoxylin and eosin (H and E). (C and E) Representative images (enlarged 400X) are from whole
Figure 9 continued on next page
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Immortalised-non-smoker one basal cells (BCi-NS1) verified by karyotyping were sourced directly
from Walters et al. (2013) and grown in Bronchial Epithelial Growth Media (BEGM, Lonza). Primary
human bronchial epithelial cells (pBECs) were obtained from four healthy individuals who had no his-
tory of smoking or lung disease, had normal lung function, and gave written, informed consent to
participate and have their data published, in accordance with the procedures approved by the Uni-
versity of Newcastle Human Ethics Committee (Project Ref. No. H-163–1205), in keeping with the
guidelines of the National Institutes of Health, American Academy of Allergy and Immunology
(Anonymous, 1991). pBECs were derived by endobronchial brushing during fibre-optic bronchos-
copy and cultured in hormonally supplemented BEGM containing 50 U/ml penicillin and 50 mg/ml
streptomycin (Wark et al., 2005).
Virus stocks were grown in Vero cells as previously (Caly et al., 2016). A549 cells were grown for
12 hr before infection with either RSV A2 (denoted as RSV throughout), or eGFP-rRSV, a recombi-
nant RSV expressing enhanced green fluorescent protein (eGFP) (Webster Marketon et al., 2014)
in 2% FCS/HF-12K medium (multiplicity of infection (MOI) of 1–3). After 2 hr, cells were washed and
media replaced; cells (or medium) at various times post infection (p.i.) were retained for analysis of
cell-associated (or released) infectious virus (plaque forming units) and/or viral genomes (by quantita-
tive PCR) as per (Caly et al., 2016).
Immunofluorescence and confocal scanning laser microscopy (CLSM)
Mock- or RSV-infected A549 cells were stained with MitoTrackerRed CMXRos (M7512, ThermoFisher
Scientific; 100 nM, 15 min) and then fixed, washed and stained using standard protocols (Hu et al.,
2013). Primary antibodies used were: anti-RSV antibody (1:400, ab20745, abcam), anti-g-tubulin anti-
body (1:300, 66320–1-Ig, Proteintech), or anti-a-tubulin (1:100, sc-5286, Santa Cruz), with dye-
tagged secondary antibodies (anti-goat Alexa Fluor 488, 1:1000, A-11055, or anti-mouse Alexa Fluor
647, 1:1000, A-31571, ThermoFisher Scientific) as appropriate. F-actin was stained by Alexa Fluor
488 phalloidin (1:1000, A12379, ThermoFisher Scientific). In all analyses of stained fixed cells, nuclei
were stained by DAPI (1:15,000 in PBS, 10236276001, Sigma). Following mounting onto glass slides
with Biomeda Gel Mount (ProSciTech), imaging was conducted using a Leica TCS SP5 channel confo-
cal and multiphoton microscope (63X objective, oil immersion). Images (512  512 pixels, 8- or 12-
bit) were collected and viewed using the Leica Application Suite Advanced Fluorescence Lite Ver-
sion: 2.8.0 build 7266 viewer software. Airyscan super-resolution imaging was performed using the
Zeiss CLSM 800 with Airyscan detector; images (2448  2448 pixels, 16-bit) were viewed using the
ZEN 2 (blue edition) software.
Quantitative analysis of mitochondrial morphology and distribution
Mitochondrial morphologies were quantified as described (Hu et al., 2013). Briefly, fragmented,
tubular or fibrillar mitochondrial morphologies were defined by width/length parameters of 1:1, 1:3
and 1:10 respectively. Quantification of each type of mitochondrial morphology in mock- or RSV-
infected cells was assessed by counting 25–30 cells per condition on three independent occasions.
Quantitative analyses of mitochondrial organization and distribution were performed using cus-
tom scripts programmed in Python using numpy (van der Walt et al., 2011), scipy, scikit-image
(van der Walt et al., 2014), matplotlib (Hunter, 2007) and seaborn (Virtanen and Oliphant, 2016;
Waskom et al., 2016; see https://gitlab.erc.monash.edu.au/mmi/mito). To quantify mitochondrial
perinuclear distribution, we measured the R90% parameter, the radius of the circle required to
enclose 90% of the MitoTrackerRed fluorescence relative to the centre of the nucleus (van Bergeijk
et al., 2015); nuclei were segmented by applying a 2-pixel Gaussian filter and an Otsu threshold
Figure 9 continued
lung sections scanned using Aperio ScanScope slide scanner. Scale bar = 100 mm. Inflammatory cell infiltrate surrounds the bronchial airway (marked by
asterisks, (C) or the blood vessels (marked by crosses, (E) in rRSV-infected samples. Each lung was scanned at three different depths. (D and F) Pooled
data for scoring the extent of (D) bronchial and (F) perivascular inflammation. The intensity of inflammation was quantitated double-blind according to
the schema described in Materials and methods (0–9 scale). Quantitation was performed on multiple lung lobes from three different depths of
sectioned tissue. Results represent the mean ± SEM (n = 15). (G) Blood was collected by cardiac puncture. Systemic inflammation was determined by
ELISA for RANTES as described in Materials and methods. Results represent the mean ± SEM (n = 5). ***p<0.001, **p<0.01.
DOI: https://doi.org/10.7554/eLife.42448.022
Hu et al. eLife 2019;8:e42448. DOI: https://doi.org/10.7554/eLife.42448 22 of 30
Research article Microbiology and Infectious Disease
(Otsu, 1979) to the DAPI channel (objects < 500 pixels were excluded). Mitochondria were then seg-
mented by applying a 2-pixel Gaussian filter and a Li threshold (Ch and Lee, 1993) to the Mito-
Tracker Red channel (objects < 10 pixels were excluded). Adjacent cells were split using a
Watershed transform where nuclei centroids situated 10 pixels apart were used as markers.
Infected cells analysed were those with mean anti-RSV-Alexa Fluor 488 fluoresence intensity 5–10 A.
U., with manual inspection of the output. The R90% was calculated by creating a Euclidean distance
map using the nuclei centroids, which was masked using the segmented mitochondrial region to
generate a map where the intensity of each pixel represents the distance of that pixel from the cen-
tre of the nucleus (i.e. the radius). A cumulative histogram was then constructed from pixel radial dis-
tances and R90% calculated as the radius within which 90% of the mitochondrial pixels were
contained.
Figure 10. Schematic representation of the progressive host cell changes that favour RSV infection. RSV infection induces changes in mitochondrial
organization with mitochondrial perinuclear clustering early in infection (8–12 h p.i.), followed by asymmetric distribution of mitochondria close to the
MTOC later in infection (18–24 h p.i.); both phases of mitochondrial redistribution (top) are dependent on dynein components (inhibited by siRNAs
directed at DYNLT1 or DYNC1H1), with perinuclear clustering limited by CLUH (siRNA directed at CLUH increases perinuclear clustering, as well as
mitochondrial ROS production and RSV virus production). Accompanying these changes, RSV infection inhibits host mitochondrial respiration, disrupts
maintenance of mitochondrial membrane potential (Dym) and enhances mitochondrial reactive oxygen species (ROS) generation. These events favour
RSV infection as indicated by fact that RSV infectious virus production is decreased by disrupting microtubule organization using nocodazole (NCZ), by
inhibiting the dynein-motor with EHNA, or using the mitochondrially-targeted antioxidant MitoQ.
DOI: https://doi.org/10.7554/eLife.42448.023
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To determine the angular distribution of mitochondrial pixels relative to the MTOC, the g-tubulin
channel was masked using the segmented mitochondrial regions as defined above. A peak detector,
as implemented by the scikit-image peak_local_max function (van der Walt et al., 2014), was used
to identify a single peak within the masked region, the coordinates of which were delineated as the
MTOC. The orientation of each cell was then normalied such that the angle of the line between the
nucleus centroid and the MTOC was equal to 0˚, that is the image was reoriented so that the MTOC
was directly above the centroid of the nucleus. To analyse the angular distribution of mitochondria,
the angle between the nucleus centroid and each pixel classified as mitochondria was calculated and
plotted as a polar kernel density histogram. Finally, the total number of mitochondria classified pix-
els falling within 45˚ either side of the MTOC were extracted and presented as a proportion of total
mitochondria classified pixels.
siRNA interference
A549 cells were transfected using DharmaFECT transfection reagent (GE Dharmacon) in serum-free
HF-12K medium with 50 nM siRNA (GE Dharmacon, SMART pool) targeting either cytoplasmic
dynein 1 heavy chain 1 (DYNC1H1, #1778), dynein light chain Tctex type 1 (DYNLT1, #6993), kinesin
light chain 1 (KLC1, #3831), clustered mitochondria homolog (CLUH, #23277), or scrambled control
siRNA (GE Dharmacon). siRNA-transfected cells were maintained in a humidified 5% CO2 atmo-
sphere at 37˚C for 48 hr before infection.
Immunoblot analysis
Cells were lysed and subjected to SDS-PAGE and immunoblot analysis as described (Hu et al.,
2013). Specific proteins were detected using anti-DYNC1H1 (1:500, C-5, sc-514579, Santa Cruz),
anti-DYNLT1 (1:1000, H-11, sc365567, Santa Cruz), anti-KLC1 (1:1000, L2, sc58776, Santa Cruz), anti-
CLUH (1:1000, PA5-71324, ThermoFisher Scientific) or anti-a-tubulin (1:5000, B-7, sc5286, Santa
Cruz) antibodies, together with anti-mouse HRP-coupled secondary antibody (1:10000, W4021,
Promega).
Assessment of mitochondrial bioenergetics and function
OCR (oxygen consumption rate) and ECAR (extracellular acidification rate) were monitored using the
Seahorse XF96 Extracellular Flux Analyser (Seahorse Biosciences) (Hu et al., 2013). A549 cells were
plated (1  104 cells/well, 10% FCS/HF-12K) with or without RSV infection (MOI 1, 2% FCS/HF12K, 2
hr). Before the measurement, cells were washed twice with pre-warmed XF assay buffer (unbuffered
DMEM supplemented with 25 mM glucose, 2 mM L-glutamine and 1 mM sodium pyruvate, pH 7.4)
and then equilibrated in XF buffer (37˚C, 1 hr). Respiratory parameters for basal, ATP-linked, maxi-
mal uncoupled, spare and non-mitochondrial respiration were calculated from OCR in response to
the sequential addition of 1 mM oligomycin (ATP synthase inhibitor), 1 mM FCCP (carbonyl cyanide
p-trifluoromethoxyphenylhydrazone, proton ionophore), and a combination of 1 mM antimycin A
(complex III inhibitor) and 1 mM rotenone (complex I inhibitor), respectively (Hu et al., 2013).
Measurement of mitochondrial membrane potential (Dcm) and ROS
Dym was determined using Dym-sensitive fluorescent dyes. For imaging with tetramethylrhodamine
ethyl ester (TMRE) (Dejonghe et al., 2016), A549 cells were mock- or eGFP-RSV-infected (MOI 1),
with TMRE (ab113852, abcam; 50 nM, 15 min; Ex/Em: 561/565 ± 25 nm) with Hoechst (H3570, Ther-
moFisher Scientific; 5 mg ml 1; Ex/Em: 405/470 nm) added for the last 5 min in the dark before imag-
ing. For live cell imaging, A549 cells were mock- or RSV-infected (MOI 3) then incubated with
tetraphenylethylene-phenyl-indolium salt (TPE-Ph-In) (2 mM, 30 min; Ex/Em: 488/680 ± 25 nm)
(Zhao et al., 2015) in the dark before imaging over 16–18 hr. To minimize phototobleaching and
phototoxicity to cells during imaging, measurements of Dym and ROS were performed using a
CLSM with 8 kHz resonant optical scanners (resonant scanning CLSM) for image resolution (512 
512 pixels, 12-bit). TMRE fluorescence intensity was quantified from 15 to 20 cells in each treatment
condition using Fiji (https://fiji.sc/).
Intracellular ROS production was visualised using dichlorodihydrofluorescein diacetate
(H2DCFDA/DCF, D399, ThermoFisher Scientific) (Al-Mehdi et al., 2012). A549 cells were mock- or
RSV-infected (MOI 1), or treated with rotenone (0.5 mM, 30 min), and treated with or without MitoQ
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(provided by Health Manufacturing, New Zealand [Smith and Murphy, 2010; Maharjan et al., 2014;
1 mM, 2 hr]), nocodazole (17 mM, 2 hr) or DMSO (vehicle) as a control. Cells were then incubated
with Mitotracker Deep Red (M22426, ThermoFisher Scientific; 100 nM, 15 min; Ex/Em: 633/665 nm),
with Hoechst and DCF (2.5 mM; Ex/Em: 496/517–527 nm) added at the last 5 min in the dark before
imaging using resonant scanning CLSM over 8–18 hr.
Mitochondrial ROS was detected using the mitochondria-targeted ROS sensor, flavin-rhodamine
redox sensor 2 (FRR2). A549 cells were mock- or RSV-infected (MOI 1) or treated with rotenone (0.5
mM, 30 min), MitoQ (1 mM, 2 hr) or DMSO (vehicle) as a control. Mitotracker Deep Red and FRR2 (2
mM, 15 min) with Hoechst (5 mg ml 1) were added in the last 5 min before live cell imaging using res-
onant scanning CLSM at 8 or 18 hr. The ratiometric output of FRR2 (Kaur et al., 2016) (I (Ex514)/I
(Ex488); the ratio of the intensity of red emission [denoted as I] at 580 ± 20 nm upon excitation [Ex] at
514 nm versus 488 nm) serves a marker for mitochondrial ROS accumulation. Ratiometric I (Ex514)/I
(Ex488) images were generated by pixel-wise division of the 514 nm and 488 nm emission image chan-
nels using Fiji. For all samples, images were set to 32-bit float precision with a display range of
min = 0.0 and max = 15.0 to facilitate comparison). To quantify the mitochondrial-localized ratio, a
CellProfiler pipeline (http://cellprofiler.org/) was set up, whereby a pixel-wise image of I (Ex514)/I
(Ex488) was derived by pixel-wise division of the emission image channels acquired at 514 nm and 488
nm excitation, and stored as a 32-bit float image. Regions containing mitochondria were then seg-
mented from the MitoTracker Deep Red channel by applying a five pixel Gaussian blur and an Otsu
auto-threshold (Otsu, 1979), and then filtered to exclude all regions smaller than 1000 pixels. Seg-
mented regions were then used to determine the mean ratiometric pixel value using the I (Ex514)/I
(Ex488) image above.
For FACS analysis, cells were trypsinised at different times, centrifuged, resuspended in FACS
buffer (2% heat-inactivated FCS, 10 mM HEPES [(4-(2-hydroxyethyl) 1-piperazineethanesulfonic
acid], 2 mM L-Glutamine, 2 mM EDTA solution) containing FRR2 (2 mM, 37˚C, 15 min), and then ana-
lysed using a BD LSRII flow cytometer. Data analysis was performed using FlowJo software (Tree
Star, Inc).
Mouse model
All experiments were performed in accordance with The ACT Animal Welfare Act (1992) and the
Australian Code of Practice for the Care and use of Animals for Scientific Purposes. The study proto-
col was approved by the Committee for Ethics in Animal Experimentation of the University of Can-
berra (project reference number CEAE 14–15). Groups of 5 BALB/c mice (6–8 weeks old) were
infected intranasally with 2.5  105 pfu of recombinant RSV (rRSV) in 50 ml as described
(Foronjy et al., 2014); control mice received 50 ml of viral diluent (mock). All mice were housed in
cages covered with barrier filters and given water containing mitochondria-specific ROS scavenger
MitoQ (500 mM) or fresh water ad libitum every day. Mice were monitored daily for signs of disease
(lethargy, ruffled fur) and weight loss. On days 3, 4, 5 and 7, mice were sacrificed using cervical dislo-
cation. One lung for each mouse was lysed in viral diluent with grinding beads using a TissueLyser II
(Qiagen) for determination of viral genomes (by quantitative PCR) and infectious virus production
(plaque forming units) per lung as per (Caly et al., 2016). The other lung from each mouse was fixed
in formaldehyde, embedded in paraffin, sectioned and stained with haemotoxylin and eosin (H and
E) (Imaging and cytometry Facility, John Curtin School of Medical Research, Australian National Uni-
versity, Canberra). Histological analysis of H and E-stained slides was used to determine bronchial
and perivascular inflammation based on established quantification schema (Ford et al., 2001;
Mehra et al., 2012). Briefly, the intensity of bronchial or perivascular inflammation was scored
numerically for each view-field on a scale of 1 to 9. 0 denotes no inflammation; 1–3 scant cells but
not forming a defined layer; 4–6, 1–3 layers of cells surrounding the airway epithelium or the vessel;
and 7–9, four or more layers of cells surrounding the airway epithelium or the vessel. Blood from
each mouse was also collected by heart puncture, serum extracted and used for ELISA to determine
systemic inflammatory responses using RANTES as a marker, as per the manufacturer’s specifications
(RANTES, RayBiotech Inc).
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Cell viability assay
A cytotoxicity detection kit (LDH Release Assay, Roche Applied Science) was used to quantitatively
assess cell death on the basis of the amount of LDH (lactate dehydrogenase) released into the
medium upon plasma membrane damage. The LDH assay was carried out as previously (Hu et al.,
2013) according to the manufacturer’s instructions.
Statistical analysis
All quantitative data in this study represent the mean value ± SEM for n  3 (number of experi-
ments). Significance levels were determined by ANOVA (GraphPad Prism 6).
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